APA (7th ed.) Citation

Ma, Y., Xu, J., & Sun, T. (2025). Research Progress in Treatment of HR-Positive/HER 2-Low Advanced Breast Cancer: Interpretation of Breast Cancer Research Hotspots in 2024 ASCO. Zhongliu fangzhi yanjiu, 52(2), 98-102. https://doi.org/10.3971/j.issn.1000-8578.2025.24.1033

Chicago Style (17th ed.) Citation

Ma, Yiwen, Junnan Xu, and Tao Sun. "Research Progress in Treatment of HR-Positive/HER 2-Low Advanced Breast Cancer: Interpretation of Breast Cancer Research Hotspots in 2024 ASCO." Zhongliu Fangzhi Yanjiu 52, no. 2 (2025): 98-102. https://doi.org/10.3971/j.issn.1000-8578.2025.24.1033.

MLA (9th ed.) Citation

Ma, Yiwen, et al. "Research Progress in Treatment of HR-Positive/HER 2-Low Advanced Breast Cancer: Interpretation of Breast Cancer Research Hotspots in 2024 ASCO." Zhongliu Fangzhi Yanjiu, vol. 52, no. 2, 2025, pp. 98-102, https://doi.org/10.3971/j.issn.1000-8578.2025.24.1033.